- Home
- GAME vs BIAF Comparison
GAME vs BIAF Comparison
Compare GAME & BIAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GAME
- BIAF
- Stock Information
- Founded
- GAME 2011
- BIAF 2014
- Country
- GAME United States
- BIAF United States
- Employees
- GAME N/A
- BIAF N/A
- Industry
- GAME
- BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- GAME
- BIAF Health Care
- Exchange
- GAME Nasdaq
- BIAF Nasdaq
- Market Cap
- GAME 23.2M
- BIAF 21.4M
- IPO Year
- GAME 2009
- BIAF 2022
- Fundamental
- Price
- GAME $0.90
- BIAF $1.24
- Analyst Decision
- GAME Strong Buy
- BIAF Strong Buy
- Analyst Count
- GAME 3
- BIAF 1
- Target Price
- GAME $3.67
- BIAF $6.00
- AVG Volume (30 Days)
- GAME 322.8K
- BIAF 102.5K
- Earning Date
- GAME 11-14-2024
- BIAF 11-14-2024
- Dividend Yield
- GAME N/A
- BIAF N/A
- EPS Growth
- GAME N/A
- BIAF N/A
- EPS
- GAME N/A
- BIAF N/A
- Revenue
- GAME $94,529,043.00
- BIAF $9,367,785.00
- Revenue This Year
- GAME $102.07
- BIAF $302.41
- Revenue Next Year
- GAME $17.85
- BIAF $15.00
- P/E Ratio
- GAME N/A
- BIAF N/A
- Revenue Growth
- GAME 159.34
- BIAF 2813.87
- 52 Week Low
- GAME $0.65
- BIAF $1.20
- 52 Week High
- GAME $2.25
- BIAF $3.62
- Technical
- Relative Strength Index (RSI)
- GAME 53.05
- BIAF 35.39
- Support Level
- GAME $0.79
- BIAF $1.21
- Resistance Level
- GAME $1.10
- BIAF $1.37
- Average True Range (ATR)
- GAME 0.11
- BIAF 0.08
- MACD
- GAME -0.00
- BIAF 0.01
- Stochastic Oscillator
- GAME 40.00
- BIAF 5.00
About GAME GameSquare Holdings Inc.
GameSquare Holdings Inc is a vertically integrated, digital media, entertainment and technology company that connects brands with gaming and youth culture audiences. The company's end-to-end platform includes Gaming Community Network (a "GCN"), a digital media company focused on gaming and esports audiences, Swingman LLC dba as Zoned, a gaming and lifestyle marketing agency, and Code Red Esports Ltd. The company's geographical segment includes the United Kingdom, the USA, and Spain. The company generates the majority of its revenue from the USA. The company's sources of revenue consist of Teams, Agency, and SaaS + Advertising.
About BIAF bioAffinity Technologies Inc.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.